The efficacy of leuprolide acetate extended-release microspheres is mainly as follows: 1. treatment of endometriosis. 2. can be used to treat symptoms of excessive menstruation, lower abdominal pain, back pain and anemia caused by uterine fibroids, and the application of this drug can also reduce the size of fibroids. 3. used in the treatment of premenopausal breast cancer, and also in the treatment of prostate cancer in men. 4. used in the treatment of central precocious puberty. In order to ensure the efficacy of the drug, it must be used under the correct usage and dosage. The dosage of this drug is different for different diseases treated. For the treatment of endometriosis, 3.75 mg of this drug should be injected subcutaneously every four weeks for adults; for the treatment of uterine fibroids, 1.88 mg of this drug should be injected subcutaneously every four weeks for adults; for the treatment of prostate cancer and premenopausal breast cancer, 3.75 mg of this drug should be injected subcutaneously every four weeks for adults; for the treatment of central precocious puberty, 30 μg/kg should be injected subcutaneously every four weeks. kg.